ResMed Inc. reports results for the quarter ended June 30 - Earnings Summary

ResMed

06/08/2026 22:39

ResMed Inc. RMD.N reported quarterly adjusted earnings of $2.95​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of $2.55.  The mean expectation of seventeen analysts for the quarter was for earnings of $2.89 per share. Wall Street expected results to range from $2.78  to $2.98 per share.
Revenue rose 8.6% to $1.46 billion from a year ago; analysts expected $1.46 billion. 
ResMed Inc.'s reported EPS for the quarter was $2.64​.
The company reported quarterly net income of $383 million.
ResMed Inc. shares had risen by 15.0% this quarter and lost 7.0% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 0.3% in the last three months.​ 
In the last 30 days, three analysts negatively revised earnings estimates
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 9 "strong buy" or "buy," 10 "hold" and 2 "sell" or "strong sell." The average consensus recommendation for the advanced medical equipment & technology peer group is  "buy."
Wall Street's median 12-month price target for ResMed Inc. is $234.00, about 4.6% above its last closing price of $223.24
This summary was machine generated from LSEG data August 6 at 09:39 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
2.89
2.95
Beat
Mar. 31 2026 
2.80
2.86
Beat
Dec. 31 2025 
2.72
2.81
Beat
Sep. 30 2025 
2.55
2.55
Met